Phase I/II Vinorelbine and Sorafenib as Salvage Therapy in Metastatic Breast Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 01 Mar 2017
At a glance
- Drugs Sorafenib (Primary) ; Vinorelbine
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 05 May 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Jul 2013 Planned end date changed from 1 Sep 2013 to 1 Sep 2014 as reported by ClinicalTrials.gov.
- 25 Jul 2012 Planned number of patients changed from 47 to 41 as reported by ClinicalTrials.gov.